Mutations in the embB Locus among Korean Clinical Isolates of Mycobacterium tuberculosis Resistant to Ethambutol .
	    		
		   		
		   			
		   		
	    	
    	- Author:
	        		
		        		
		        		
			        		Hye Young LEE
			        		
			        		
			        		
			        			1
			        			
			        		
			        		
			        		
			        		
			        		;
		        		
		        		
		        		
			        		Han Jung MYOUNG
			        		
			        		;
		        		
		        		
		        		
			        		Hye Eun BANG
			        		
			        		;
		        		
		        		
		        		
			        		Gill Han BAI
			        		
			        		;
		        		
		        		
		        		
			        		Sang Jae KIM
			        		
			        		;
		        		
		        		
		        		
			        		Joo Deuk KIM
			        		
			        		;
		        		
		        		
		        		
			        		Sang Nae CHO
			        		
			        		
		        		
		        		
		        		
			        		
			        		Author Information
			        		
 - Publication Type:Original Article ; Research Support, Non-U.S. Gov't
 - Keywords: M. tuberculosis; ethambutol resistance; embB mutations
 - MeSH: Antitubercular Agents/*pharmacology; Chromosome Mapping; Drug Resistance, Bacterial; Ethambutol/*pharmacology; *Mutation; Mycobacterium tuberculosis/*drug effects/genetics; Pentosyltransferases/*genetics; Polymerase Chain Reaction
 - From:Yonsei Medical Journal 2002;43(1):59-64
 - CountryRepublic of Korea
 - Language:English
 - Abstract: Resistance of Mycobacterium tuberculosis to ethambutol (EMB) has been assigned to an operon, embCAB, which has been proposed to be a structural gene for mycobacterial arabinosyl transferases. Recently, genetic events resulting in structural mutations at embB have been proposed as major contributors to the EMB-resistance of isolates whose minimum inhibitory concentration (MIC) level is higher than 20 microgram/ml. On the contrary, isolates with a MIC level lower than 20 microgram/ml do not seem to contain any sequence alterations. In this study, in an effort to understand the role of embB mutations at a low-level of EMB resistance, we investigated the sequence polymorphisms of clinical isolates whose MIC levels are lower than 10 microgram/ml. Accordingly, the sequence alterations of a 312-bp region of the embB gene containing the 306th codon, which has been assigned as a hot-spot for EMB-resistance related mutations, were determined for 21 EMB-resistant and 5 EMB-susceptible clinical isolates. In brief, among 21 EMB- resistant isolates examined, 12 (57.1%) contained mutations in embB (10 at the 306th codon and 2 at other sites), and the remaining isolates 9 contained no mutations in any region of embB. The observed mutations included M306V, M306I, and M306L substitutions that have been reported previously. However, 3 were novel types, which included M306T, A313G and Y322C, D331Y double substitutions. On the other hand, all of the EMB-susceptible isolates were found to be free of mutations. In conclusion, our findings suggest that sequence polymorphism of embB may play a pivotal role in the EMB- resistance of M. tuberculosis.
 
            